Ryszard Smolarczyk - Concepedia

Author

Ryszard Smolarczyk

The Maria Sklodowska-Curie National Research Institute of Oncology ORCID

Also Known As

R SMOLARCZYK, R Smolarczyk, R. Smolarczyk, RYSZARD SMOLARCZYK, Ryszard Smolarczyk

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology Medical University of Silesia University of Silesia in Katowice Silesian Center for Heart Disease Silesian University of Technology

About

Ryszard Smolarczyk is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, immunology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	566
2	Engineering	1	1	22
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	15
5	Biochemistry	1	1	15

Ryszard Smolarczyk

Publications

970

Citations

H-Index

Page 1

	Year	Citations
Overexpression of Heme Oxygenase-1 in Murine Melanoma Halina Waś, Tomasz Cichoń, Ryszard Smolarczyk, American Journal Of Pathology Tumor BiologyMelanomaMurine MelanomaPathologyHeme Homeostasis	2006	192
M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma Magdalena Jarosz–Biej, Natalia Kamińska, Sybilla Matuszczak, PLoS ONE Tumor-associated MacrophagesImmunologyNk CellsBiological MicroenvironmentsImmunoediting	2018	79
The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy Ryszard Smolarczyk, Tomasz Cichoń, Sybilla Matuszczak, Archivum Immunologiae et Therapiae Experimentalis	2012	78
The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells Justyna Czapla, Sybilla Matuszczak, Klaudia Kulik, Stem Cell Research & Therapy	2019	73
Antitumor effect of RGD-4C-GG-D(KLAKLAK)2 peptide in mouse B16(F10) melanoma model. Ryszard Smolarczyk, Tomasz Cichoń, Klaudyna Graja, Acta Biochimica Polonica Chemoprevention StrategyImmunologyCell DeathPeptide ScienceCancer Biology	2006	63
Active heat shock transcription factor 1 supports migration of the melanoma cells via vinculin down-regulation Agnieszka Toma-Jonik, Joanna Korfanty, Tomasz Cichoń, Cellular Signalling Vinculin Down-regulationMolecular RegulationActive Hsf1Melanoma CellsTumor Biology	2014	44
Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents Joanna Jazowiecka-Rakus, Tomasz Cichoń, Magdalena Głowala‐Kosińska, Gene Therapy VaccinationTherapeutic Antitumor PotentialEndoglin-based Dna VaccineVaccine DevelopmentImmunology	2012	43
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors Ryszard Smolarczyk, Tomasz Cichoń, Ewelina Pilny, Scientific Reports Melanoma TumorsImmunologyNk CellsPathologyCancer Biology	2018	42
Human ADSC xenograft through IL-6 secretion activates M2 macrophages responsible for the repair of damaged muscle tissue Ewelina Pilny, Ryszard Smolarczyk, Magdalena Jarosz–Biej, Stem Cell Research & Therapy	2019	41
Anticancer effects of CAMEL peptide Ryszard Smolarczyk, Tomasz Cichoń, Wojciech Kamysz, Laboratory Investigation MedicinePeptide LibraryImmunologyCamel PeptidePharmacotherapy	2010	32

Page 1